Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2013 Jun;12(3):418-28.
doi: 10.1007/s12311-012-0421-3.

Inventory of Non-Ataxia Signs (INAS): validation of a new clinical assessment instrument

H Jacobi  1 , M Rakowicz, R Rola, R Fancellu, C Mariotti, P Charles, A Dürr, M Küper, D Timmann, C Linnemann, L Schöls, O Kaut, C Schaub, A Filla, L Baliko, B Melegh, J-S Kang, P Giunti, B P C van de Warrenburg, R Fimmers, T Klockgether
Affiliations
Multicenter Study

Inventory of Non-Ataxia Signs (INAS): validation of a new clinical assessment instrument

H Jacobi et al. Cerebellum. 2013 Jun.

Abstract

Although ataxia is by definition the prominent symptom of ataxia disorders, there are various neurological signs that may accompany ataxia in affected patients. Reliable and quantitative assessment of these signs is important because they contribute to disability, but may also interfere with ataxia. Therefore we devised the Inventory of Non-Ataxia Signs (INAS), a list of neurological signs that allows determining the presence and severity of non-ataxia signs in a standardized way. INAS underwent a rigorous validation procedure that involved a trial of 140 patients with spinocerebellar ataxia (SCA) for testing of inter-rater reliability and another trial of 28 SCA patients to assess short-term intra-rater reliability. In addition, data of the ongoing EUROSCA natural history study were used to determine the reproducibility, responsiveness and validity of INAS. Inter-rater reliability and short-term test-retest reliability was high, both for the total count and for most of the items. However, measures of responsiveness, such as the smallest detectable change and the clinically important change were not satisfactory. In addition, INAS did not differentiate between subjects that were subjectively stable and those that worsened in the 2-year observation period. In summary, INAS and INAS count showed good reproducibility, but unsatisfactory responsiveness. The present analysis and published data from the EUROSCA natural history study suggest that INAS is a valid measure of extracerebellar involvement in progressive ataxia disorders. As such, it is useful as a supplement to the measures of ataxia, but not as a primary outcome measure in future interventional trials.

PubMed Disclaimer

Similar articles

  • Responsiveness of different rating instruments in spinocerebellar ataxia patients.
    Schmitz-Hübsch T, Fimmers R, Rakowicz M, Rola R, Zdzienicka E, Fancellu R, Mariotti C, Linnemann C, Schöls L, Timmann D, Filla A, Salvatore E, Infante J, Giunti P, Labrum R, Kremer B, van de Warrenburg BP, Baliko L, Melegh B, Depondt C, Schulz J, du Montcel ST, Klockgether T. Schmitz-Hübsch T, et al. Neurology. 2010 Feb 23;74(8):678-84. doi: 10.1212/WNL.0b013e3181d1a6c9. Neurology. 2010. PMID: 20177122
  • Long-term disease progression in spinocerebellar ataxia types 1, 2, 3, and 6: a longitudinal cohort study.
    Jacobi H, du Montcel ST, Bauer P, Giunti P, Cook A, Labrum R, Parkinson MH, Durr A, Brice A, Charles P, Marelli C, Mariotti C, Nanetti L, Panzeri M, Rakowicz M, Sulek A, Sobanska A, Schmitz-Hübsch T, Schöls L, Hengel H, Baliko L, Melegh B, Filla A, Antenora A, Infante J, Berciano J, van de Warrenburg BP, Timmann D, Szymanski S, Boesch S, Kang JS, Pandolfo M, Schulz JB, Molho S, Diallo A, Klockgether T. Jacobi H, et al. Lancet Neurol. 2015 Nov;14(11):1101-8. doi: 10.1016/S1474-4422(15)00202-1. Epub 2015 Sep 13. Lancet Neurol. 2015. PMID: 26377379
  • Spinocerebellar ataxia types 1, 2, 3, and 6: disease severity and nonataxia symptoms.
    Schmitz-Hübsch T, Coudert M, Bauer P, Giunti P, Globas C, Baliko L, Filla A, Mariotti C, Rakowicz M, Charles P, Ribai P, Szymanski S, Infante J, van de Warrenburg BP, Dürr A, Timmann D, Boesch S, Fancellu R, Rola R, Depondt C, Schöls L, Zdienicka E, Kang JS, Döhlinger S, Kremer B, Stephenson DA, Melegh B, Pandolfo M, di Donato S, du Montcel ST, Klockgether T. Schmitz-Hübsch T, et al. Neurology. 2008 Sep 23;71(13):982-9. doi: 10.1212/01.wnl.0000325057.33666.72. Epub 2008 Aug 6. Neurology. 2008. PMID: 18685131
  • Monitoring disease progression in spinocerebellar ataxias: implications for treatment and clinical research.
    Sarro L, Nanetti L, Castaldo A, Mariotti C. Sarro L, et al. Expert Rev Neurother. 2017 Sep;17(9):919-931. doi: 10.1080/14737175.2017.1364628. Epub 2017 Aug 13. Expert Rev Neurother. 2017. PMID: 28805093 Review.
  • Ataxia rating scales--psychometric profiles, natural history and their application in clinical trials.
    Saute JA, Donis KC, Serrano-Munuera C, Genis D, Ramirez LT, Mazzetti P, Pérez LV, Latorre P, Sequeiros J, Matilla-Dueñas A, Jardim LB; Iberoamerican Multidisciplinary Network for the Study of Movement Disorders (RIBERMOV) Study Group. Saute JA, et al. Cerebellum. 2012 Jun;11(2):488-504. doi: 10.1007/s12311-011-0316-8. Cerebellum. 2012. PMID: 21964941 Review.
See all similar articles

Cited by

See all "Cited by" articles

References

    1. J Chronic Dis. 1986;39(11):897-906 - PubMed
    1. Neurology. 2006 Jun 13;66(11):1717-20 - PubMed
    1. Neurology. 2010 Feb 23;74(8):678-84 - PubMed
    1. Med Care. 1989 Mar;27(3 Suppl):S178-89 - PubMed
    1. Neurology. 2008 Sep 23;71(13):982-9 - PubMed

Publication types

LinkOut - more resources